228 related articles for article (PubMed ID: 34086681)
1. Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study from a public tertiary hospital.
Lim TZ; Lau J; Wong GJ; Tan KK
PLoS One; 2021; 16(6):e0250460. PubMed ID: 34086681
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
[TBL] [Abstract][Full Text] [Related]
3. Short Term Outcomes of Using Fecal Immunochemical Test for a Pilot Colorectal Cancer Screening Program. A Single Center Study on 3024 Consecutive Patients.
Constantin A; Cazacu I; Ciocârlan M; Constantinescu C; Baltog G; Balahura C; Doraş I; Filip S; Filip G; Panazan I; Piţigoi D; Pirvu V; Turcu F; Copăescu C; Săftoiu A
Chirurgia (Bucur); 2020; 115(4):448-457. PubMed ID: 32876018
[No Abstract] [Full Text] [Related]
4. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
6. Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
Zorzi M; Battagello J; Selby K; Capodaglio G; Baracco S; Rizzato S; Chinellato E; Guzzinati S; Rugge M
Gut; 2022 Mar; 71(3):561-567. PubMed ID: 33789965
[TBL] [Abstract][Full Text] [Related]
7. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
[TBL] [Abstract][Full Text] [Related]
8. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
Lee YC; Fann JC; Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Hsu CY; Hsu WF; Wu MS; Chen HH
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1332-1340.e3. PubMed ID: 30391435
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
[TBL] [Abstract][Full Text] [Related]
10. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.
Alsayid M; Singh MH; Issaka R; Laleau V; Day L; Lee J; Allison J; Somsouk M
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1593-1597.e1. PubMed ID: 29660528
[TBL] [Abstract][Full Text] [Related]
11. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
12. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
13. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
14. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
15. Are hemoglobin levels really lower in faecal immunochemical test positive patients with colorectal cancer?
Ng JY; Tan IJ; Tan KK
Surgeon; 2018 Feb; 16(1):36-39. PubMed ID: 28108269
[TBL] [Abstract][Full Text] [Related]
16. Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.
van de Schootbrugge-Vandermeer HJ; Kooyker AI; Wisse PHA; Nagtegaal ID; Geuzinge HA; Toes-Zoutendijk E; de Jonge L; Breekveldt ECH; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Lansdorp-Vogelaar I; Spaander MCW; van Leerdam ME
Endoscopy; 2023 Dec; 55(12):1061-1069. PubMed ID: 37793423
[TBL] [Abstract][Full Text] [Related]
17. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
[TBL] [Abstract][Full Text] [Related]
18. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
[TBL] [Abstract][Full Text] [Related]
19. Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bos ACRK; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1237-1243.e2. PubMed ID: 29427732
[TBL] [Abstract][Full Text] [Related]
20. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]